For: | Lee CF, Ling ZQ, Zhao T, Fang SH, Chang WC, Lee SC, Lee KR. Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma. World J Gastroenterol 2009; 15(3): 356-365 [PMID: 19140237 DOI: 10.3748/wjg.15.356] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i3/356.htm |
Number | Citing Articles |
1 |
Florian Wiede, Tony Tiganis. PTPN2: a tumor suppressor you want deleted?. Immunology & Cell Biology 2017; 95(10): 859 doi: 10.1038/icb.2017.70
|
2 |
Jia Wang, Xiang Zheng, Qiu Peng, Xuemei Zhang, Zailong Qin. Eph receptors: the bridge linking host and virus. Cellular and Molecular Life Sciences 2020; 77(12): 2355 doi: 10.1007/s00018-019-03409-6
|
3 |
Han Kiat Ho, Boon Tin Chua, Winnie Wong, Kah Suan Lim, Vivian Teo, Hooi-Tin Ong, Xiao Chen, Wei Zhang, Kam M. Hui, Mei Lin Go, Axel Ullrich. Benzylidene‐indolinones are effective as multi‐targeted kinase inhibitor therapeutics against hepatocellular carcinoma. Molecular Oncology 2014; 8(7): 1266 doi: 10.1016/j.molonc.2014.04.008
|
4 |
Amjad P. Khan, Laila M. Poisson, Vadiraja B. Bhat, Damian Fermin, Rong Zhao, Shanker Kalyana-Sundaram, George Michailidis, Alexey I. Nesvizhskii, Gilbert S. Omenn, Arul M. Chinnaiyan, Arun Sreekumar. Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer. Molecular & Cellular Proteomics 2010; 9(2): 298 doi: 10.1074/mcp.M900159-MCP200
|
5 |
Joanna L Fox, Ferina Ismail, Abul Azad, Nicola Ternette, Sabrina Leverrier, Mariola J Edelmann, Benedikt M Kessler, Irene M Leigh, Sarah Jackson, Alan Storey. Tyrosine dephosphorylation is required for Bak activation in apoptosis. The EMBO Journal 2010; 29(22): 3853 doi: 10.1038/emboj.2010.244
|
6 |
Mihwa Kim, Liza D. Morales, Cheol Jung Lee, Serena A. Olivarez, Woo Jin Kim, Joselin Hernandez, Srinivas Mummidi, Christopher Jenkinson, Andrew T. Tsin, Ik-Soon Jang, Thomas J. Slaga, Dae Joon Kim. Overexpression of TC-PTP in murine epidermis attenuates skin tumor formation. Oncogene 2020; 39(21): 4241 doi: 10.1038/s41388-020-1282-8
|
7 |
Liang Song, Tammy Robson, Tamasin Doig, Thomas Brenn, Marie Mathers, Ewan R Brown, Val Doherty, John M S Bartlett, Niall Anderson, David W Melton. DNA repair and replication proteins as prognostic markers in melanoma. Histopathology 2013; 62(2): 343 doi: 10.1111/j.1365-2559.2012.04362.x
|
8 |
John R. Bergquist, Amy Y. Li, Christopher S. Javadi, Byrne Lee, Jeffrey A. Norton, George A. Poultsides, Monica M. Dua, Brendan C. Visser. Regional lymph node sampling in hepatoma resection: insight into prognosis. HPB 2021; 23(9): 1360 doi: 10.1016/j.hpb.2021.01.006
|
9 |
Gaoyuan Wang, Sarah T. Diepstraten, Marco J. Herold. Last but not least: BFL-1 as an emerging target for anti-cancer therapies. Biochemical Society Transactions 2022; 50(4): 1119 doi: 10.1042/BST20220153
|
10 |
Shiyan Li, Fengjuan Han, Na Qi, Liyang Wen, Jia Li, Cong Feng, Qingling Wang. Determination of a six-gene prognostic model for cervical cancer based on WGCNA combined with LASSO and Cox-PH analysis. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02384-2
|
11 |
Dawei Wang, Wenmu Wang, Mingge Song, Yishi Xie, Wenbin Kuang, Peng Yang. Regulation of protein phosphorylation by PTPN2 and its small-molecule inhibitors/degraders as a potential disease treatment strategy. European Journal of Medicinal Chemistry 2024; 277: 116774 doi: 10.1016/j.ejmech.2024.116774
|
12 |
Jingfeng Zhang, Sifeng Hu, Yansen Li. KRT18 is correlated with the malignant status and acts as an oncogene in colorectal cancer. Bioscience Reports 2019; 39(8) doi: 10.1042/BSR20190884
|
13 |
Xue Li, Junwei Dou, Qidong You, Zhengyu Jiang. Inhibitors of BCL2A1/Bfl-1 protein: Potential stock in cancer therapy. European Journal of Medicinal Chemistry 2021; 220: 113539 doi: 10.1016/j.ejmech.2021.113539
|
14 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 91 doi: 10.1007/978-3-319-26956-6_4
|
15 |
Zuo-Lin Xiang, Zhao-Chong Zeng, Jia Fan, Zhao-You Tang, Hai-Ying Zeng, Dong-Mei Gao. Gene Expression Profiling of Fixed Tissues Identified Hypoxia-Inducible Factor-1α, VEGF, and Matrix Metalloproteinase-2 as Biomarkers of Lymph Node Metastasis in Hepatocellular Carcinoma. Clinical Cancer Research 2011; 17(16): 5463 doi: 10.1158/1078-0432.CCR-10-3096
|
16 |
Dong‑Yue Wen, Jia‑Cheng Huang, Jie‑Yu Wang, Wen‑Ya Pan, Jiang‑Hui Zeng, Yu‑Yan Pang, Hong Yang. Potential clinical value and putative biological function of miR‑122‑5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data. Oncology Letters 2018; doi: 10.3892/ol.2018.9523
|
17 |
Andrea Diviney, Boris I. Chobrutskiy, Saif Zaman, George Blanck. An age-based, RNA expression paradigm for survival biomarker identification for pediatric neuroblastoma and acute lymphoblastic leukemia. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0790-5
|
18 |
Oleksandr Lytovchenko, Edmund R.S. Kunji. Expression and putative role of mitochondrial transport proteins in cancer. Biochimica et Biophysica Acta (BBA) - Bioenergetics 2017; 1858(8): 641 doi: 10.1016/j.bbabio.2017.03.006
|
19 |
John E. La Marca, Lee F. Willoughby, Kirsten Allan, Marta Portela, Pei Kee Goh, Tony Tiganis, Helena E. Richardson. PTP61F Mediates Cell Competition and Mitigates Tumorigenesis. International Journal of Molecular Sciences 2021; 22(23): 12732 doi: 10.3390/ijms222312732
|
20 |
Peng Shen, Aijuan Wang, Mengye He, Qingqing Wang, Shusen Zheng. Increased circulating Lin−/lowCD33+HLA‐DR− myeloid‐derived suppressor cells in hepatocellular carcinoma patients. Hepatology Research 2014; 44(6): 639 doi: 10.1111/hepr.12167
|
21 |
David P. Labbé, Serge Hardy, Michel L. Tremblay. Protein Phosphorylation in Health and Disease. Progress in Molecular Biology and Translational Science 2012; 106: 253 doi: 10.1016/B978-0-12-396456-4.00009-2
|
22 |
Florian Wiede, Sock Hui Chew, Catherine van Vliet, Ingrid J. Poulton, Konstantinos Kyparissoudis, Tedjo Sasmono, Kim Loh, Michel L. Tremblay, Dale I. Godfrey, Natalie A. Sims, Tony Tiganis, Jean Kanellopoulos. Strain-Dependent Differences in Bone Development, Myeloid Hyperplasia, Morbidity and Mortality in Ptpn2-Deficient Mice. PLoS ONE 2012; 7(5): e36703 doi: 10.1371/journal.pone.0036703
|
23 |
Cynthia Veenstra, Elin Karlsson, Sanam Mirwani Mirwani, Bo Nordenskjöld, Tommy Fornander, Gizeh Pérez-Tenorio, Olle Stål. The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype. Journal of Cancer Research and Clinical Oncology 2019; 145(7): 1845 doi: 10.1007/s00432-019-02918-y
|
24 |
Julie Lecomte, Anne Masset, Dylan R. Edwards, Agnès Noël. Tumor-Associated Fibroblasts and their Matrix. 2011; : 175 doi: 10.1007/978-94-007-0659-0_10
|
25 |
Zhihong Yang, Yuxia Zhang, Li Wang, Chun-Ming Wong. A Feedback Inhibition between miRNA-127 and TGFβ/c-Jun Cascade in HCC Cell Migration via MMP13. PLoS ONE 2013; 8(6): e65256 doi: 10.1371/journal.pone.0065256
|
26 |
Stephanie L. Fowler, Mark Akins, Hu Zhou, Daniel Figeys, Steffany A.L. Bennett. The Liver Connexin32 Interactome Is a Novel Plasma Membrane-Mitochondrial Signaling Nexus. Journal of Proteome Research 2013; 12(6): 2597 doi: 10.1021/pr301166p
|
27 |
Meike Vogler. Targeting BCL2-Proteins for the Treatment of Solid Tumours. Advances in Medicine 2014; 2014: 1 doi: 10.1155/2014/943648
|
28 |
Veerabrahma Pratap Seshachalam, Karthik Sekar, Kam M Hui. Insights into the etiology‐associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas. Journal of Gastroenterology and Hepatology 2018; 33(12): 2037 doi: 10.1111/jgh.14262
|
29 |
Rui Liang, Mingo M. H. Yung, Fangfang He, Peili Jiao, Karen K. L. Chan, Hextan Y. S. Ngan, David W. Chan. The Stress-Inducible BCL2A1 Is Required for Ovarian Cancer Metastatic Progression in the Peritoneal Microenvironment. Cancers 2021; 13(18): 4577 doi: 10.3390/cancers13184577
|
30 |
Peter A van Dam, Christian Rolfo, Rossana Ruiz, Patrick Pauwels, Christophe Van Berckelaer, XuanBich Trinh, Jose Ferri Gandia, Johannes P. Bogers, Steven Van Laere. Potential new biomarkers for squamous carcinoma of the uterine cervix. ESMO Open 2018; 3(4): e000352 doi: 10.1136/esmoopen-2018-000352
|
31 |
Elif Karaca Atabay, Carmen Mecca, Qi Wang, Chiara Ambrogio, Ines Mota, Nina Prokoph, Giulia Mura, Cinzia Martinengo, Enrico Patrucco, Giulia Leonardi, Jessica Hossa, Achille Pich, Luca Mologni, Carlo Gambacorti-Passerini, Laurence Brugières, Birgit Geoerger, Suzanne D. Turner, Claudia Voena, Taek-Chin Cheong, Roberto Chiarle. Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma. Blood 2022; 139(5): 717 doi: 10.1182/blood.2020008136
|
32 |
Ran Tao, Jun Li, Jiaojiao Xin, Jian Wu, Jing Guo, Liyuan Zhang, Longyan Jiang, Wu Zhang, Zhe Yang, Lanjuan Li, Rakesh K. Srivastava. Methylation Profile of Single Hepatocytes Derived from Hepatitis B Virus-Related Hepatocellular Carcinoma. PLoS ONE 2011; 6(5): e19862 doi: 10.1371/journal.pone.0019862
|
33 |
Md Easin Hasan, Fahad Mostafa, Md S. Hossain, Jonathon Loftin. Machine-Learning Classification Models to Predict Liver Cancer with Explainable AI to Discover Associated Genes. AppliedMath 2023; 3(2): 417 doi: 10.3390/appliedmath3020022
|
34 |
Mo-Wei Kong, Yang Yu, Ying Wan, Yu Gao, Chun-Xiang Zhang. From biomarker discovery to combined therapies: Advancing hepatocellular carcinoma treatment strategies. World Journal of Gastrointestinal Oncology 2024; 16(11): 4518-4521 doi: 10.4251/wjgo.v16.i11.4518
|
35 |
|
36 |
|
37 |
M Vogler. BCL2A1: the underdog in the BCL2 family. Cell Death & Differentiation 2012; 19(1): 67 doi: 10.1038/cdd.2011.158
|
38 |
Bob Meeusen, Veerle Janssens. Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification. The International Journal of Biochemistry & Cell Biology 2018; 96: 98 doi: 10.1016/j.biocel.2017.10.002
|
39 |
Lokesh P. Tripathi, Chikako Kataoka, Shuhei Taguwa, Kohji Moriishi, Yoshio Mori, Yoshiharu Matsuura, Kenji Mizuguchi. Network based analysis of hepatitis C virus Core and NS4B protein interactions. Molecular BioSystems 2010; 6(12): 2539 doi: 10.1039/c0mb00103a
|
40 |
Sanjib Dutta, T. Scott Chen, Amy E. Keating. Peptide Ligands for Pro-survival Protein Bfl-1 from Computationally Guided Library Screening. ACS Chemical Biology 2013; 8(4): 778 doi: 10.1021/cb300679a
|
41 |
Renzhuo Gao, Dan Zhou, Xingpeng Qiu, Jiayi Zhang, Daya Luo, Xiaohong Yang, Caiyun Qian, Zhuoqi Liu. Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review. Cancer Control 2024; 31 doi: 10.1177/10732748241287905
|
42 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_4-1
|
43 |
Elin Karlsson, Cynthia Veenstra, Shad Emin, Chhanda Dutta, Gizeh Pérez-Tenorio, Bo Nordenskjöld, Tommy Fornander, Olle Stål. Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer. Breast Cancer Research and Treatment 2015; 153(1): 31 doi: 10.1007/s10549-015-3516-y
|
44 |
Patrizia Virdis, Irene Marchesi, Francesco Paolo Fiorentino, Rossana Migheli, Luca Sanna, Valentina Bordoni, Giorgio Pintore, Grazia Galleri, Maria Rosaria Muroni, Luigi Bagella, Claudio Fozza, Maria Rosaria De Miglio, Luigi Podda. Tomentosin a Sesquiterpene Lactone Induces Antiproliferative and Proapoptotic Effects in Human Burkitt Lymphoma by Deregulation of Anti- and Pro-Apoptotic Genes. Life 2021; 11(11): 1128 doi: 10.3390/life11111128
|